MedTrace Logo

Oral Nutritional Supplementation in Amyotrophic Lateral Sclerosis (ALS) Patients

NCT02152449 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 229

Last updated 2021-08-19

No results posted yet for this study

Summary

The purpose of this study is to determine whether an early oral nutritional supplementation (ONS) in amyotrophic lateral sclerosis (ALS) patients is effective on the treatment of this rapidly progressive disease.

Conditions

  • Amyotrophic Lateral Sclerosis (ALS)

Interventions

DIETARY_SUPPLEMENT

Oral nutritional supplementation

Sponsors & Collaborators

  • Laboratoires NUTRICIA

    collaborator OTHER

  • University Hospital, Limoges

    lead OTHER

Principal Investigators

  • Philippe COURATIER, MD · CHU Limoges

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2019-07-31
Completion
2021-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02152449 on ClinicalTrials.gov